Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

The Journal of allergy and clinical immunology - 1 Nov 2010

Ng Wan-Fai, von Delwig Alexei, Carmichael Andrew J, Arkwright Peter D, Abinun Mario, Cant Andrew J, Jolles Stephen, Lilic Desa

Abstract excerpt

BACKGROUND: Accumulating evidence implicates T(H)17 cytokines in protection against Candida species infections, but the clinical relevance is not clear. Chronic mucocutaneous candidiasis (CMC) is a heterogeneous syndrome with the unifying feature of selective susceptibility to chronic candidiasis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIRE Protein
Share to Candidiasis, Chronic Mucocutaneous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Separation

Share to Cytokines

Share to Enzyme-Linked Immunosorbent Assay

Share to Flow Cytometry

Share to Polyendocrinopathies, Autoimmune

Share to Th17 Cells

Source

Identifiers

PMID: 20934207
DOI: 10.1016/j.jaci.2010.08.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20934207-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.PMID 20934207Read ↗

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.Semantic proximity Read ↗

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.Semantic proximity Read ↗

Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunitySemantic proximity Read ↗

Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasisSemantic proximity Read ↗

New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.Semantic proximity Read ↗

TH17 deficiency in human disease.Semantic proximity Read ↗

Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies.Semantic proximity Read ↗

Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.Semantic proximity Read ↗

Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review.Semantic proximity Read ↗

Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.Semantic proximity Read ↗

Biological and clinical significance of T helper 17 cell deficiency: insight into monogenic defects.Semantic proximity Read ↗

Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.